Home | Events | Stockholm 2024 | Abstracts

Abstracts

Check the important dates and tips to inspire the future of research

Abstracts

Thank you, inspiring authors!

Thank you to the authors of 2,201 Abstracts for being an inspiration and shaping the future of research at ERA24. Your enthusiasm and dedication to inspire change, innovation, and progress in research have been truly amazing.

Submitted Abstracts will be reviewed by the Congress Paper Selection Committee. The presenting author of each accepted/rejected abstract can check the status of their submitted Abstract/s on My ERA on March 18, 2024, starting from 2:00 PM (CET).

Contacts & Resources

For further inquiries, please contact:
abstracts@era-online.org
Ordinary Travel Grants & ASQ Travel Grants Regulations 

Important dates
Abstracts & travel grant Notification
March 18, 2024 at 14:00 (CET)

Latest news

Late Breaking Clinical Trial submission has been closed on March 14, 2024.

At the upcoming 61st ERA Congress in Stockholm (May 23-26, 2024), one of the Late Breaking Clinical Trial sessions (Friday, May 24, 12:00 – 13:15) will highlight the results of the Flow study.
Peter Rossing, Richard Pratley, Vlado Prekovic, Johannes Mann and Katherine R. Tuttle will present the results of the study and the session will conclude with an independent commentary by Christoph Wanner.

The FLOW study is a carefully designed, randomised, double-blind, parallel-group, placebo-controlled, superiority trial comparing the effects of Semaglutide with placebo when added to standard of care in people with type 2 diabetes and chronic kidney disease (CKD).
The study, which started in 2019, has successfully recruited 3,534 participants from 28 different countries.

Its primary objective is to demonstrate the potential to delay the progression of CKD and reduce the risk of renal and cardiovascular mortality. This will be assessed by a comprehensive composite primary endpoint comprising five key components: the occurrence of a persistent ≥ 50% reduction in estimated glomerular filtration rate (eGFR1) according to the CKD-EPI2 equation compared to baseline, the occurrence of a persistent eGFR1 (CKD-EPI2) < 15 mL/min/1.73 m2, the initiation of chronic renal replacement therapy (dialysis or kidney transplant), death from kidney disease or death from cardiovascular disease in people with type 2 diabetes and CKD. In addition, key secondary endpoints include annual rate of change in eGFR1 (CKD-EPI2), major adverse cardiovascular events (non-fatal myocardial infarction, non-fatal stroke, cardiovascular death) and all-cause death.

Shape

Abstract submission tutorial

Preparing an Abstract

Tips for getting your abstract accepted

Good luck!

Ronald Gansevoort

Ronald Gansevoort

Chair of the Paper Selection Committee

The submitted abstracts are reviewed by an abstract selection committee. Everyone on the abstract selection committee is asked to review around 25 to 40 different abstracts. It is therefore important that you try to convey the background (why is this study relevant?), aims, methods, results, and conclusions of your study as clearly and concisely as possible.

Please use headers:

  1. Background and aims
  2. Methods
  3. Results
  4. Conclusions

Present only the important results for the reviewer to interpret.

Base your conclusions only on the data presented within the abstract. Give actual p values rather stating p<0.05.

Try to ensure the English correctly conveys the intended meaning – if English is not your first language it may be useful to ask someone to review your abstract before submitting.

It can sometimes be helpful in putting a clear message across to have different headings in the abstract. It will certainly make it much easier for the abstract judges to give your work the credit it deserves.

We recommend you start with BACKROUND AND AIMS in which you explain the background of the problem or area you are going to present information about.

Here you should also describe the rationale for what you are presenting. Why is it interesting or important? In addition – it might be a trial of one therapy against another for example, or an observational study of the natural history of something.

The second section should be METHODS in which you explain clearly and concisely how you approached the study, what you did, and how you analysed the information. Please indicate whether it was an observational study or a trial, whether the observational study was retrospective, cross-sectional or prospective, whether the trial was randomized, blinded etc?

The next section should be RESULTS in which you present the main findings, as text, tables or figures. Clarity here is vital to success of a good abstract. Please do not tease us by saying “results will be presented”!

Finally, the CONCLUSIONS in which you state the main findings of this piece of work and how this has advanced knowledge and understanding.

FAQ - General information

Frequently asked questions about Abstracts General Information. Please note that the information below is constantly being updated.

What is an Abstract?

An Abstract is a concise summary of a presentation, paper or research study that provides a snapshot of the content, allowing readers to understand the focus and significance of the work without having to read the entire presentation.

Abstracts submitted to ERA 2024 should relate to any aspect of nephrology, the prevention and treatment of kidney disease and related conditions, or the scientific background to the study of the kidney.

The aim of an Abstract is to capture the essence of the presentation in a concise and engaging manner. It should be clear, concise and informative, enticing ERA 2024 attendees to learn more about your work during the Congress.

How do I submit an Abstract?

All Abstracts must be submitted electronically via the Congress website using the weblink below from November 6, 2023, to January 16, 2024.

https://era.m-anage.com/Login.aspx?event=era24

You will need to access your My ERA account using your login details (for ERA members and returning users). If you are a first-time user, you will need to create your own account.

Only submission via the Congress website is possible. Abstracts submitted by post or e-mail will not be accepted.

Is there a template to download, or can I use mine?

It is mandatory to use the template provided under the Upload tab on the ABSTRACT SUBMISSION page.

To ensure that the format is correct, copy and paste your content without formatting (even if our system recognises many fonts) into the file and save it under a new name.

What is the Abstract’s required structure?

Your Abstract should consist of four paragraphs labelled “Background and Aims”, “Methods”, “Results” and “Conclusions” and cannot exceed 3600 characters (space not included). The template headings are part of the counting and cannot be deleted.

Images, tables, and graphs may be included, but please note that tables and graphs do not count as characters when inserted as an image.

Title: Must be concise, and eye-catching

Background and Aims: in which you explain the background of the problem or area you are going to present information about. Why is it interesting, or important? Here you should also describe the rationale for what you are presenting – it might be a trial of one therapy against another for example, or a study of the natural history of something.

Methods: in which you explain clearly and concisely how you approached the study, what you did, and how you analyzed the information.

Results: in which you present the main findings, as text, tables or figures. Clarity here is vital for the success of a good Abstract. Please do not tease us by saying “results will be presented”!

Conclusion: in which you state the main findings of this piece of work and how this has advanced knowledge and understanding.

Will case report Abstracts be considered?

Yes, ERA will accept case report Abstracts.

Who reviews my Abstract?

Submitted Abstracts will be reviewed by the Congress Paper Selection Committee. The abstract review process is conducted in strict confidence and is fully blinded. During this process, reviewers are not made aware of information such as the title, authors or their affiliations.

ERA’s advice for getting your Abstract accepted

Present only the important results for the reviewer to interpret.

Base your conclusions only on the data presented in the Abstract. Give actual p-values rather than stating p<0.05.

Please ensure that the Abstract follows the structure described above.

In which language should the Abstract be submitted?

Your Abstract must be in ENGLISH, please check for typos and spelling errors as your Abstract will not be proofread by the Society.

Try to ensure that the English conveys the intended meaning correctly – if English is not your first language, it may be useful to ask someone to proofread your Abstract before submission.

Do I need to disclose any conflict of interest while submitting my Abstract?

Yes, all Abstract submitters are required to complete a simplified Disclosure of Interest (DOI) form during the submission process. If, after review, the Abstract is accepted for inclusion in the Congress, they will be asked to complete the full DOI form when submitting their presentation.

How much does sending an Abstract to ERA cost?

There is a non-refundable processing fee of EUR 25 for each Abstract submitted.

The processing fee must be paid at the time of submission by credit card only. Major credit cards (MasterCard and Visa) are accepted for secure online payment. All payments must be received by 23:59 CET on Tuesday, January 16, 2024, for the submission to be considered successful. This fee is non-refundable even if the Abstract is rejected.

Abstract processing fees are waived for submitters from countries with an official annual income (GDP – Gross Domestic Product per capita) of less than USD 10,000 (source: World Bank).

List of eligible countries

Where will my Abstract be published?

Accepted Abstracts will be published in an online NDT supplement published by Oxford University Press on behalf of ERA.

There will be no printed Abstract book.

Abstracts will appear exactly as submitted. Abstracts deemed unsuitable for reproduction will not be published.

What about the copyright of my Abstract once published?

All authors of Abstracts grant ERA the right to make the Abstract available to the public and to all other users via the ERA website and any other websites operated by ERA, as well as via social media or other websites related to medical issues, for an indefinite period of time, without territorial limitation and without any right to compensation.

For further information, please refer to the ERA Terms and Conditions.

Accepted Abstracts will also be published in an online NDT Supplement with the following copyright line: ©The Author(s) 2024. Published by Oxford University Press on behalf of ERA. All rights reserved. For permissions, please email: journals.permissions@oup.com

Can I submit Late Breaking Clinical Trials?

Results of Late Breaking Clinical trials of exceptional importance that have not been presented elsewhere may be submitted via the Congress website from February 15, 2024, to March 14, 2024.

If data analysis could not be performed before the regular Abstract deadline, studies submitted through this Late Breaking Trial track that do not meet these criteria will not be considered for presentation.

What are the prerequisites for the Late Breaking Clinical Trials submission?

Prospective randomized clinical trials with at least 100 randomized patients.

Prospective observational studies with at least 500 patients in the follow-up.

A prospective, randomised intervention in the pathology of rare renal diseases, with no limit on the number of patients enrolled.

What are the benefits of sending Late Breaking Clinical Trials to ERA?

The best Abstracts will be selected for presentation at the LBCT Symposium and the remaining Abstracts that comply with the rules will be accepted as Focussed Oral.

The remaining Abstracts, including those that do not comply with the LBCT rules, will be automatically rejected.

Authors of LBCT Abstracts accepted for the Symposium will be offered free registration, 1 free night accommodation in Stockholm and travel expenses. (All details regarding these benefits will be emailed to presenting authors of accepted LBCT abstracts).

What about the Abstract presenter registration?

All authors presenting an Abstract must register for the Congress.

Whether the Abstract is accepted or rejected, all Abstract submitters will benefit from the reduced fee.

For further information please contact: era-registration@interplan.de

All Abstracts must be uploaded to the official Congress platform in advance. Authors presenting Abstracts must be pre-registered for the Congress in order to upload their work before May 9, 2024.

Please note that you do not need to register for your Abstract to be published in the NDT supplement.

FAQ - Abstract submission

Frequently asked questions about Abstracts submission. Please note that the information below is constantly being updated.

Who can I contact if I have problems with the submission procedure?

Please contact us at abstracts@era-online.org

I missed the deadline to submit an Abstract. Can I still submit an Abstract?

Abstract submissions will not be permitted after the deadline.

No exceptions will be made.

Can I submit multiple Abstracts?

Yes, there is no limit on how many Abstracts you can submit.

Can I submit already published Abstracts?

No, submitted Abstracts must describe unpublished work that is not already in press or awaiting possible acceptance by any other society that publishes its Abstracts/proceedings.

Encore Abstracts, papers already presented at another meeting will not be considered.

Papers already accepted for publication will not be considered.

Do I receive a confirmation upon my Abstract submission?

Yes, all authors of correctly written and successfully submitted Abstracts will receive a confirmation by e-mail.

How long can my Abstract be?

Abstracts submitted to ERA24 must not exceed 3600 characters (excluding spaces) and you will not be able to finalise your submission if you exceed this limit.

Can I add tables and figures?

Yes, you can include one figure and one table, two figures or two tables. Tables should be in an editable format and figures should meet the following requirements JPEG or PNG format, 1200 dpi for line drawings and 300 dpi for colour and halftone illustrations. We encourage you to provide colour figures (there is no charge for this). Please pay particular attention to the quality of your figures! All tables and figures MUST be accompanied by a legend.

Please note that tables do not count as characters when inserted as an image.

Do tables count in the max. number of characters?

Tables created with the Microsoft Words table function are counted as characters. The text within the table is counted in the same way as in the text area.

Note that tables are not counted as characters when inserted as an image.

Do figures count towards the overall 3600-character limit?

No, figures don’t count towards the overall 3600-character limit.

Is there a character limit for the legends? If not, do they count towards the overall 3600-limit?

If the legend is created within the table function in Microsoft Word, the text within the table is counted, if the legend is a single image or is embedded within another image, it doesn’t count.

Is there a character limit for the Abstract title? If not, does it count towards the overall 3600-character limit?

Yes, the Abstract title must be written within 150 characters, and it does not count towards the overall 3600-character limit.

What about references?

References are optional, but if you choose to include them, please do not include more than 5 and follow these requirements:

References should be numbered in the order in which they appear in the text.

At the end of the Abstract, the full list of references should include the names and initials of all authors, unless there are more than six, in which case only the first three should be given, followed by et al. The authors’ names should be followed by the title of the article, the title of the journal abbreviated in the style of Index Medicus, the year of publication, the volume number, and the first and last page numbers.

References to books should include the title of the book, followed by the place of publication, the publisher, the year and the relevant pages

Do the references count in the character count?

Yes, references count towards the maximum 3600 characters allowed.

My Abstract has many co-authors, can I list them all?

No, Abstracts submitted to ERA cannot have more than 12 authors.

Should all authors approve the final Abstract?

The presenting author must confirm in good faith that all co-authors have agreed to the submission and content of the Abstract. ERA cannot be held responsible for any breach of this rule.

Does the first author and/or presenting author need to be the same person?

No, the presenting author doesn’t have to be the first author. The presenting author can be any of the authors of the Abstract.

Is there a maximum number of affiliations allowed per author?

The maximum number of affiliations per author is 12.

FAQ - Abstract results announcement

Frequently asked questions about Abstracts results announcement. Please note that the information below is constantly being updated.

I have submitted my Abstract, what happens next?

Your Abstract will be reviewed by the ERA24 Congress Paper Selection Committee.

The presenting author of each accepted/rejected Abstract will be notified on March 18, 2024, starting from 2:00 PM CET. 

If accepted, the Abstract will be published in the online NDT supplement.

How do I know in which format my accepted Abstract must be presented at the Congress?

This will be stated in the email to the presenting author confirming acceptance of the Abstract.

Can I choose the final format of my Abstract presentation?

No, the final selection will be made by the ERA24 Congress Paper Selection Committee, the schedule and format cannot be changed.

My Abstract has been accepted as Free Communication. How will it be presented at the Congress?

The highest-scoring Abstracts will be presented as free communications, combined in sessions with mini-lectures by world-renowned scientists.

Presentation and Q&A times will be communicated by email.

All Abstracts accepted as free communication will be published in the final programme under the respective free communication session. Only the name of the presenting author and country will be published in the Congress Final Programme.

The presenter MUST be present in person, not virtually.

If the presenting author is unable to present the Abstract, another co-author may take his/her place. However, if this is the case, an email from the presenting author is mandatory and must be sent to program@era-online.org as soon as possible.

My Abstract has been accepted as Focussed Oral. How will it be presented at the Congress?

Focussed Oral must be presented live and in person and will not be recorded or live-streamed.

Presenting authors will present their Abstracts directly on the screen in a dedicated session in Stockholm and will have the opportunity to answer questions from the audience.

Presentation and Q&A times will be communicated by email.

If the presenting author is unable to present the Abstract, another co-author may take his/her place. However, if this is the case, an email from the presenting author explaining the change is mandatory and must be sent to program@era-online.org as soon as possible.

Focussed Oral presentations will not appear in the final programme.

My Abstract has been accepted as Moderated Oral. How will it be presented at the Congress?

The highest-scoring Abstracts that are not suitable for free communication must be presented separately.

The presenter should be present in person, not virtually.

Presentation and Q&A times will be communicated by email.

If the presenting author is unable to present the Abstract, another co-author may take his or her place. However, if this is the case, an email from the presenting author explaining the change is mandatory and must be sent to program@era-online.org as soon as possible.

Moderated Oral presentations will not appear in the final programme.

My Abstract has been accepted as e-Poster. How will it be presented at the Congress?

The e-Poster format is strictly virtual and not on-site.

Accepted e-Poster Abstracts will be available ONLY on the virtual platform at all times during the Congress.

We recommend that you switch to this format if your Abstract has previously been accepted as a Free Communication, Moderated Oral or Focussed Oral and you are unable to attend the Congress on-site, if so please send us an e-mail to program@era-online.org as soon as possible.

e-Posters will not appear in the final programme.

Do I need to print the e-Poster if I plan to come onsite?

No, accepted e-Poster Abstracts will be visible ONLY on the virtual platform during the Congress, there is no need to print your e-Poster.

Do I get a special certificate?

Yes, a special certificate will be issued to the presenting author only, indicating the percentile achieved by the Abstract(s).

Is there a special template to be used for presentations?

Yes, all ERA accepted Abstracts must use the official ERA template.

As soon as it is ready, it will be available for download from our website.

If you have any problems accessing it, please e-mail us at abstracts@era-online.org.

Can I present virtually if the Abstract is accepted?

All accepted Abstracts (Free Communication, Moderated Orals and Focussed Orals accepted Abstracts) must be presented onsite in Stockholm.

If you cannot physically attend the Conference, you can still submit an Abstract.

If the Abstract is accepted, it will be displayed on the conference website regardless of your participation type (virtual or onsite).

All the accepted Abstracts will be published in our online NDT supplement, which will be online two weeks before the Congress by the beginning of May 2024.

FAQ - Withdrawal/changes

Frequently asked questions about Abstracts withdrawal/changes. Please note that the information below is constantly being updated.

Can I withdraw my Abstract?

Yes, if you would like to withdraw your Abstract, please send an e-mail to abstracts@era-online.org by mid-March 2024.

Please note that once an Abstract has been published in the online NDT supplement, it cannot be withdrawn.

Can I make changes to the Abstract after submission?

No changes are allowed.

Once the Abstract has been submitted and the upload deadline has passed, the ERA 2024 Congress Paper Selection Committee has immediate access to begin the review process. For this reason, an Abstract cannot be changed after submission.

If you need to change the list of authors or any other changes that may affect the content of the Abstract, please send an email to abstracts@era-online.org by 13 March 2024.

Any changes to the author list must be approved by all authors of the Abstract (written confirmation).

Please note that once an Abstract has been published in the online NDT supplement, no further changes can be made.

I chose the wrong category for my Abstract, can I change it?

Yes, you can, but only until the Abstract submission deadline.

Once the Abstract has been submitted and the upload deadline has passed, the ERA 2024 Congress Paper Selection Committee has immediate access to begin the review process. For this reason, the Abstract category cannot be changed after the submission deadline.

If we change the presenting author of our Abstract, will he/she be eligible for the Congress membership discount?

No, only the original presenting author is eligible for the Congress membership discount.

FAQ - Travel Grants for Young Nephrologists

Frequently asked questions about Travel Grants for Young Nephrologists. Please note that the information below is constantly being updated.

How do I apply for an ERA Travel Grant?

In order to apply for these grants, applicants must select the option “Yes, I am applying for the ERA Travel Grant and I am less than 40 years of age” during the Abstract submission process, under the “Custom Queries” page.

Please note that you can only apply during the Abstract submission process between November 6, 2023, and January 16, 2024.

What is the ERA Travel Grant?

The ERA offers up to a max. amount of EUR 1000 in travel grants to ERA members who are not older than 40 in the year in which the event is held. The amount of each Travel Grant is calculated by considering the applicant’s Abstract score and the distance between the city/country of residence and the city/country where the event is being held.

  1. Within the 8 best Abstracts submitted by young authors: 2 per main category (basic, clinical, dialysis and transplantation) – EUR 1000, free registration to ERA 2024 Congress and a special diploma.
  2. Within the 80 best Abstracts submitted by young authors: 20 per main category (basic, clinical, dialysis and transplantation) – EUR 500, free registration to ERA 2024 Congress and a special certificate.
  3. Within the same applicant’s city in which the event is being held – EUR 100, free registration to ERA 2024 Congress and a special certificate.

How will the Travel Grants be distributed?

ERA Headquarters will be responsible for collecting all Grant applications. The Travel Grant budget will be approved by the Committee. Once the allocation has been completed, the ERA Headquarters will notify the winners by e-mail.

How do I collect my travel grant?

Travel Grant recipients must complete the form included in the letter of acceptance and return it to abstracts@era-online.org.

Payment of the travel grant is subject to the actual attendance of the grant holder at the Congress, who must present a valid identity card to the ERA staff present at the faculty desk during the days of the Congress and fill in and sign the relevant form.

Travel Grants are exclusive and cannot be given to anyone else. No exceptions will be made. Payment of the grant will be made by bank transfer after the event. ERA cannot be held responsible for incorrect information provided by the grantee, which may lead to delays in the payment of the grant.

The Travel Grant will NOT be awarded if ERA has already covered the applicant’s hotel and/or travel expenses.

Does ERA help young Abstract authors from developing countries?

Yes, a certain number of grants will be given to presenting authors of accepted Abstracts (younger than 45) coming from developing countries (GDP less than USD 10,000 a year – World Bank database).

The number of grants should not be more than 10, with a minimum of 4, for each Congress: the final number will depend on how many replies will be received to the Congress survey feedback questionnaire, sent the year before (normally, for each 200 replies, one grant will be given).

The grant consists of a free Congress membership and a contribution of EUR 300 to help cover the travel expenses to attend the Congress.

The final selection of the winners will be done by the Congress Paper Selection Committee Chair taking into consideration the following parameters:

Age of the presenting author of the Abstract (preference will be given to the younger authors);

  • The GDP of the Country of residence (preference will be given to the Countries with lower GDP);
  • The world geographical area: the geographical area of the selected winners must be distributed as equally as possible.
  • Quality of the Abstract (preference will be given to the better Abstracts).

A list of eligible countries can be found here.

When will I be notified if I have won the ERA travel grant?

All applicants will receive an acceptance/rejection letter by mid-March 2024.